Bliss Gvs Pharma Ltd Financial Statement - Bliss Gvs Pharma Ltd Balance Sheet | Research 360 by Motilal Oswal
15:53 Apr 16

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
112.20
+1.90 (+1.72%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
112.20
+1.90 (+1.72%)
15:53 Apr 16
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

57/100
Affordable Valuation

Technical

45/100
Technically Neutral

Strength

5

Weakness

5

Opportunity

1

Threats

0

8.01 %

ROE %

6.12 %

ROA %

6.72

EPS

88.08

BVPS

9.42 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
689.31 577.21 747.45 751.59 756.9
Operating Expenses +
565.99 470.56 629.12 634.27 628.38
Raw Material
435.67 340.79 420.18 374.38 373.94
Increase Decrease in Cost
4.3 -11.88 -29.2 26.94 21.69
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
53.69 68.09 76.15 86.17 93.58
Miscellaneous Expenses
423.67 235.52 231.81 235.46 139.17
Operating Profit
123.32 106.65 118.33 117.32 128.52
Other Income
39.19 20.22 31.49 17.79 26.11
Depreciation
12.59 17.23 17.33 18.67 24.41
Interest
7.57 5.51 4.74 10.36 10.14
Profit before tax and exceptio..
142.35 104.13 127.76 106.07 120.08
Exceptional Items
-13.38 0 -73.59 0 0
PBT
128.97 104.13 54.17 106.07 120.08
Provision for Taxation
33.71 30.16 31.04 29.34 30.11
Net Profit
95.25 73.97 23.13 76.73 89.94
NET Profit after MI
97.26 68.49 15.04 70.86 87.95
EPS
9.43 6.64 1.46 6.72 8.45
Operating Profit Margin (%)
17.89 18.48 15.83 15.61 16.98
Net Profit Margin (%)
14.11 11.87 2.01 9.43 11.62

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 35.00 35.00 35.10 35.10 35.00
FII 14.70 15.40 16.30 16.50 16.60
MF - - - - -
Public 43.70 43.10 42.00 41.70 41.70
Others 6.60 6.50 6.60 6.70 6.70
Shareholder Shares Holding %

Download Our App On: